James P Bartels, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 30 Canton St, Ste 2, Manchester, NH 03103 Phone: 603-622-3623 Fax: 603-625-5483 |
Dr. Judson R Belmont, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 130 Tarrytown Rd, Manchester, NH 03103 Phone: 603-669-0831 Fax: 603-669-4088 |
Dr. Richard H Lee, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 130 Tarrytown Rd, Manchester, NH 03103 Phone: 603-669-0831 Fax: 603-669-4088 |
Dr. Jeffrey M Zimmerman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 30 Canton St, Ste 2, Manchester, NH 03103 Phone: 603-622-3623 Fax: 603-625-5483 |
Dr. Colin Edwards, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 30 Canton St Ste 2, Manchester, NH 03103 Phone: 603-622-3623 Fax: 513-475-8228 |
Dr. Andrew Ryan Spector, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 30 Canton St, Manchester, NH 03103 Phone: 603-622-3623 Fax: 603-625-5483 |
News Archive
"State leaders, trying to dig out of a hole in the current two-year budget before the next one has to be whacked, ordered agencies Tuesday to further curb spending. Agency chiefs were told in a letter that they must reduce expenditures by 2.5% in the remaining nine months of the fiscal year. Managers of the state Medicaid program immediately announced they would cut another 1% from the fees paid to doctors, dentists and hospitals, along with 2% in payments to nursing homes and home health care providers. The decreases take effect Feb. 1, and they come on top of 1% cuts that kicked in just before Labor Day" (Garrett, 12/8).
In a surprising reversal, researchers have determined that a particular protocol providing physical therapy to ICU patients with acute respiratory failure did not shorten hospital length of stay.
The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) awarded a $51 million contract to Emergent BioSolutions, Inc., of Rockville, Md., for the development of a new anthrax vaccine using the protective antigen (rPA) to stimulate a protective immune response that neutralizes the anthrax toxins.
Scientists at The University of Texas MD Anderson Cancer Center have discovered the signaling pathway whereby a master regulator of cancer cell proteins - known as Src - leads to ovarian cancer progression when exposed to stress hormones. The researchers report in the current issue of Nature Communications that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.
› Verified 1 days ago